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eight percent would consider the information when prescribing.
Seventy-ﬁve percent of the proﬁled physicians who responded
agreed that the proﬁles were informative and useful, and 67%
would consider the information in their prescribing decisions.
CONCLUSION: Providing antibiotic prescribing proﬁles for
physicians may inﬂuence prescribing patterns and maintain cost
in a managed care setting.
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OBJECTIVES: To compare—in terms of effectiveness and
costs—outpatient management of infantile bronchiolitis by
homeopathic GPs vs allopathic GPs vs paediatricians.
METHODS: A 6-month prospective, “real-world” study was
carried out by setting up 3 observatories with: homeopathic GPs,
allopathic GPs and paediatricians recruited by sample-drawing.
Patients aged between 3 and 24 months, consulting for ﬁrst bout
of acute bronchiolitis since birth, who had not yet received treat-
ment and who did not require immediate hospitalisation were
included. Effectiveness (number and duration of bouts, number
of complications, persistence of bronchial obstruction), direct
medical costs (from the French Health Insurance and societal
perspectives) and indirect costs (sick leaves) were assessed. The
statistical analysis was performed after matching patients to have
comparable patients. RESULTS: One hundred seventeen, 150
and 253 patients were respectively included by 38 homeopathic
GPs, 59 allopathic GPs and 95 paediatricians. At the end of the
study, there were: no signiﬁcant differences between the man-
agement by homeopathic GPs vs allopathic GPs on effectiveness
criteria; no signiﬁcant differences between the management by
homeopathic GPs vs paediatricians in terms of number of bouts,
persistence of bronchial obstruction but signiﬁcant shorter dura-
tion of bouts (4.4 vs 6.6 days) and less complications (0.20 vs
0.40 complication/patient) in the homeopathic group. In Health
Insurance perspective, the management by homeopathic GPs was
signiﬁcantly less expensive than the management by allopathic
GPs and paediatricians (116, 146, 217 €/patient respectively). In
the societal perspective, the management by homeopathic GPs
was signiﬁcantly less expensive than the management by paedi-
atricians (215 vs 361 €/patient) but equivalent to the manage-
ment by allopathic GPs. Homeopathic GPs prescribed equivalent
number of sick leaves to paediatricians but signiﬁcantly less than
allopathic GPs. CONCLUSION: These results could help public
policy makers and practitioners in providing new available data
concerning the outpatient management and cost of infantile
bronchiolitis, that is a public health concern in France.
PIN29
THE ECONOMIC EVALUATION OF INFLUENZA
VACCINATION IN THE ELDERLY POPULATION: A MODEL
BASED ON BAYESIAN NETWORKS
Baio G1, Pammolli F1, Baldo V2,Trivello R2
1University of Florence, Florence, Italy; 2University of Padua, Padua,
Italy
OBJECTIVES: Inﬂuenza infection is a major cause of illness,
morbidity and mortality throughout the world, mainly among
the elderly. Since vaccination has proven to be effective in the
reduction of all acute complications, deciding whether to imple-
ment a vaccination campaign, and which vaccine(s) to prescribe
is an important task. The aim of this work is to build a decision
model, which allows the decision-makers to evaluate the possi-
ble results under different scenarios, and to choose the decision
associated to the highest expected utility, in terms of incremen-
tal cost effectiveness ratio (ICER). METHODS: The analysis is
based on the Bayesian Networks. We developed a network that
combines information from an observational study conducted in
Pianiga (Italy) from a group of GPs (Family Medicine Group),
with literature and experts data. This information was used to
create a graph model, which encodes the set of conditional inde-
pendencies among the variables. The probabilities of the relevant
events (mortality and resources consumption) are calculated
using the network. A (dis)utility function, represented by direct
costs, is associated to the decision of implementing or not the
vaccination campaign with a given vaccine. The ICER is then
derived for several possible scenarios. RESULTS: The MF59
vaccine proves to be more cost-effective, as compared to both
the non-vaccination and the standard vaccine. This result is con-
sistent through several scenarios, built upon varying parameters
such as coverage and attack rates. In the basic scenario, obtained
by observed data, MF59 allows a saving of 16,444€ per death
averted, with respect to standard vaccine, and a saving of 
2718 € per death averted as compared to non vaccination. CON-
CLUSIONS: Using Bayesian Networks can help structure the
decision problem and allow for a direct multivariate stochastic
sensitivity analysis. The use this tool is in our opinion highly
valuable, yet not established, in health economics.
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OBJECTIVES: In this observational study, we analyzed the
minimum basic data sets (MBDS) together with the associated
medication costs, relating to stays from 11 hospitals. We focused
on Pneumonia stays considering the effect of antibiotic treatment
(SDT versus parenteral therapy), stay parameters and patient
characteristics on length of stay (LOS) and the resulting antibi-
otic national insurance cost. METHODS: Belgian hospitals 
register case mix data for admissions in MBDS: we extracted
anonymous medical data and prescribed drug cost data from
stays of 11 peripheral Flemish hospitals (during 2001). MBDS
contains ICD-9-CM codes and performed procedures as well as
other stay parameters (severity, risk of mortality, LOS), patient
characteristics (age, gender) and drug utilization data. Data were
stored in MS Access 2000 and analyzed in SPSSWIN 12.0. Stays
were considered independent; LOS and cost data were log trans-
formed to obtain homoscedasticity. RESULTS: The database
contained 302,704 patient stays: 6742 relate to pneumonia.
Pneumococcus pneumonia was reported in 472 stays (461
patients). Mean (SD) LOS was 16.3 (21.9) days; 89 % of the
admissions were unscheduled. Mortality was 8.1%. The 
frequency of antibiotic use was: Amoxicillin-Clavulanate 
63.9%, cephalosporins third generation 30,8%, quinolones
16.8%, cephalosporins second generation 15.7%, macrolides
15.7%, aminoglycosides 15.3%. In 48,9% one, in 25% two and
in 12% three AB-classes were administered. 37.7% SDT therapy
was used. LOS was unaffected by SDT but there was a signiﬁ-
cant effect (p < 0.001 Anova) of age, stay severity and the
